Elicio Therapeutics, Inc.

ELTX · Nasdaq · SIC 2834: Pharmaceutical Preparations
119
SEC Filings

Business Summary

EX-24.1 6 eltx-powerofattorney2025.htm EX-24.1 eltx-powerofattorney2025 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ELICIO THERAPEUTICS, INC. By: /s/ ROBERT CONNELLY Date: March 12, 2026 Robert Connelly President and Chief Executive Officer (Principal Executive Officer) By: /s/ PREETAM SHAH, PH.D., M.B.A. Date: March 12, 2...

Next Earnings

Q2 FY2026 — expected 2026-09-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionELTXdiscussed_in_filing Healthcare & Bio
topic_mentionELTXdiscussed_in_filing Healthcare & Bio
topic_mentionELTXdiscussed_in_filing Healthcare & Bio
topic_mentionELTXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001601485-26-000027EDGAR111K words
2025-03-312024-12-310001601485-25-000049EDGAR—
2024-03-292023-12-310001601485-24-000023EDGAR—
2023-03-172022-12-310001601485-23-000011EDGAR—
2022-03-302021-12-310001601485-22-000022EDGAR—
2021-03-302020-12-310001601485-21-000007EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001601485-25-000124EDGAR20K words
2025-08-072025-06-300001601485-25-000111EDGAR—
2025-05-132025-03-310001601485-25-000074EDGAR—
2024-11-132024-09-300001601485-24-000075EDGAR—
2024-08-132024-06-300001601485-24-000045EDGAR—
2024-05-152024-03-310001601485-24-000033EDGAR—
2023-11-132023-09-300001601485-23-000082EDGAR—
2023-08-142023-06-300001601485-23-000052EDGAR—
2023-05-102023-03-310001601485-23-000035EDGAR—
2022-11-142022-09-300001601485-22-000070EDGAR—
2022-08-152022-06-300001601485-22-000066EDGAR—
2022-05-162022-03-310001601485-22-000037EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-160001601485-26-000032EDGAR24K words
2026-03-120001601485-26-000026EDGAR—
2025-11-130001601485-25-000123EDGAR—
2025-09-170001193125-25-205522EDGAR—
2025-08-120001601485-25-000114EDGAR—
2025-08-070001601485-25-000108EDGAR—
2025-08-050001601485-25-000099EDGAR—
2025-06-040001601485-25-000096EDGAR—
2025-05-200001601485-25-000076EDGAR—
2025-05-130001601485-25-000072EDGAR—

119 total filings indexed. 91 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001601485
TickerELTX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f897d0aa2b0e417342a4379aa1d8e2d2bddfca9628e9e79dfb9a810a46089361
parent: b8ad210b7c2e0aca9cd5ca60b02393a37a9546bb5ba1e1df4526f36a5203984f
content hash: 80707200c98a197a5413494c4df9b255a0242ed32aa97c0597a4522d5cdadcbb
signed: 2026-04-13T04:44:50.310Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf